8-K
Current Report
Keros Therapeutics, Inc. Filed Acc 0001664710-20-000042
Agreement ended
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading keros-form8xknnpr10x30.htm…